title: China rejects patent on hepatitis C drug sofosbuvir.
authors.affiliation: The BMJ.
authors.forename: Zosia
authors.initials: Z
authors.lastname: Kmietowicz
mesh_terms: D000998:Antiviral Agents / Q000191:economics / Q000627:therapeutic use; D002681:China; D003363:Cost Control / Q000379:methods*; D016527:Drug Costs; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D011358:Product Surveillance, Postmarketing / Q000191:economics; D000069474:Sofosbuvir; D014542:Uridine Monophosphate / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D014542:Uridine Monophosphate; D000069474:Sofosbuvir